Replies to post #169156 on Biotech Values

[genisi]

The fact that this MRK regimen is a viable player in the all oral HCV arena was hinted before (#msg-93015431) and is becoming more clear with the AASLD abs.

[DewDiligence]

Re: MRK's HCV data

Please see #msg-93665051, which should be read in conjunction with genisi's reply in #msg-93647662.